These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9213630)

  • 1. Biological diversity, indigenous knowledge, drug discovery and intellectual property rights: creating reciprocity and maintaining relationships.
    King SR; Carlson TJ; Moran K
    J Ethnopharmacol; 1996 Apr; 51(1-3):45-57. PubMed ID: 9213630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intellectual property rights and traditional medicine: policy dilemmas at the interface.
    Timmermans K
    Soc Sci Med; 2003 Aug; 57(4):745-56. PubMed ID: 12821021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodiversity prospecting and benefit-sharing: perspectives from the field.
    Soejarto DD
    J Ethnopharmacol; 1996 Apr; 51(1-3):1-15. PubMed ID: 9213606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juridical and sociocultural problems on the definition of a law concerning property, usage and access to genetic resources in Colombia.
    Calle R
    J Ethnopharmacol; 1996 Apr; 51(1-3):127-42; discussion 142-6. PubMed ID: 9213609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legal issues in sharing the benefits of biodiversity prospecting.
    Mays TD; Mazan KD
    J Ethnopharmacol; 1996 Apr; 51(1-3):93-102; discussion 102-9. PubMed ID: 9213633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The position of intellectual property rights in drug discovery and development from natural products.
    Boyd MR
    J Ethnopharmacol; 1996 Apr; 51(1-3):17-25; discussion 25-7. PubMed ID: 9213613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanzania's policy on biodiversity prospecting and drug discovery programs.
    Mahunnah RL; Mshigeni KE
    J Ethnopharmacol; 1996 Apr; 51(1-3):221-8. PubMed ID: 9213620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 25 years after the `Rio Convention'--Lessons learned in the context of sustainable development and protecting indigenous and local knowledge.
    Heinrich M; Hesketh A
    Phytomedicine; 2019 Feb; 53():332-343. PubMed ID: 30318154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From shaman to human clinical trials: the role of industry in ethnobotany, conservation and community reciprocity.
    King SR; Tempesta MS
    Ciba Found Symp; 1994; 185():197-206; discussion 206-13. PubMed ID: 7736855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnobotany and intellectual property rights.
    Barton JH
    Ciba Found Symp; 1994; 185():214-21; discussion 221-7. PubMed ID: 7736856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicinal plant genetic resources and international cooperation: the Brazilian perspective.
    Elisabetsky E; Costa-Campos L
    J Ethnopharmacol; 1996 Apr; 51(1-3):111-9; discussion 119-20. PubMed ID: 9213607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Studies on biodiversity of Vietnam and Laos" 1998-2005: examining the impact.
    Soejarto DD; Zhang HJ; Fong HH; Tan GT; Ma CY; Gyllenhaal C; Riley MC; Kadushin MR; Franzblau SG; Bich TQ; Cuong NM; Hiep NT; Loc PK; Xuan le T; Hai NV; Hung NV; Chien NQ; Binh le T; Vu BM; Ly HM; Southavong B; Sydara K; Bouamanivong S; Pezzuto JM; Rose WC; Dietzman GR; Miller BE; Thuy TV
    J Nat Prod; 2006 Mar; 69(3):473-81. PubMed ID: 16562860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodiversity prospecting in Nigeria: seeking equity and reciprocity in intellectual property rights through partnership arrangements and capacity building.
    Iwu MM
    J Ethnopharmacol; 1996 Apr; 51(1-3):209-19. PubMed ID: 9213619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interests and policies of the state of Sarawak, Malaysia regarding intellectual property rights for plant derived drugs.
    Chung FJ
    J Ethnopharmacol; 1996 Apr; 51(1-3):201-4. PubMed ID: 9213617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Academic research: policies and practice.
    Bertha SL
    J Ethnopharmacol; 1996 Apr; 51(1-3):59-73. PubMed ID: 9213631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intellectual Property Rights, Naturally Derived Bioactive Compounds and Resource Conservation. Proceedings of the American Society of Pharmacognosy interim annual meeting. San Jose, Costa Rica, October 20-22, 1994.
    J Ethnopharmacol; 1996 Apr; 51(1-3):ix-xi, 1-330. PubMed ID: 9213605
    [No Abstract]   [Full Text] [Related]  

  • 17. Geospatial patterns in traditional knowledge serve in assessing intellectual property rights and benefit-sharing in northwest South America.
    Cámara-Leret R; Paniagua-Zambrana N; Svenning JC; Balslev H; Macía MJ
    J Ethnopharmacol; 2014 Dec; 158 Pt A():58-65. PubMed ID: 25456422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intellectual property rights in Costa Rica in the light of the Biodiversity Convention].
    Salazar R; Cabrera JA
    J Ethnopharmacol; 1996 Apr; 51(1-3):177-93. PubMed ID: 9213615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural product source material use in the pharmaceutical industry: the Glaxo experience.
    Turner DM
    J Ethnopharmacol; 1996 Apr; 51(1-3):39-43; discussion 44. PubMed ID: 9213629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research, valorization and exploitation of biological resources for medicinal purposes in the Malagasy Republic (Madagascar).
    Randimbivololona F
    J Ethnopharmacol; 1996 Apr; 51(1-3):195-200. PubMed ID: 9213616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.